These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 11035045)

  • 21. Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells.
    Kim KY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW
    J Pharmacol Exp Ther; 2004 Jan; 308(1):97-104. PubMed ID: 14569058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
    Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
    Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of threonine 10 on CKBBP1/SAG/ROC2/Rbx2 by protein kinase CKII promotes the degradation of IkappaBalpha and p27Kip1.
    Kim YS; Lee JY; Son MY; Park W; Bae YS
    J Biol Chem; 2003 Aug; 278(31):28462-9. PubMed ID: 12748192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation regulates the stability of the regulatory CK2beta subunit.
    Zhang C; Vilk G; Canton DA; Litchfield DW
    Oncogene; 2002 May; 21(23):3754-64. PubMed ID: 12032843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase.
    Wang X; Gjörloff-Wingren A; Saxena M; Pathan N; Reed JC; Mustelin T
    J Immunol; 2000 Feb; 164(4):1934-9. PubMed ID: 10657643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
    Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
    J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple forms of protein kinase CK2 present in leukemic cells: in vitro study of its origin by proteolysis.
    Roig J; Krehan A; Colomer D; Pyerin W; Itarte E; Plana M
    Mol Cell Biochem; 1999 Jan; 191(1-2):229-34. PubMed ID: 10094413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/Akt/ cyclic AMP response element binding protein via maxi-K channel opening in neuronal cells.
    Kim KY; Lee JH; Park JH; Yoo MA; Kwak YG; Kim SO; Yoo SE; Hong KW
    Eur J Pharmacol; 2004 Aug; 497(3):267-77. PubMed ID: 15336944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383.
    Tolkacheva T; Boddapati M; Sanfiz A; Tsuchida K; Kimmelman AC; Chan AM
    Cancer Res; 2001 Jul; 61(13):4985-9. PubMed ID: 11431330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling.
    Song DH; Dominguez I; Mizuno J; Kaut M; Mohr SC; Seldin DC
    J Biol Chem; 2003 Jun; 278(26):24018-25. PubMed ID: 12700239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
    Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
    Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
    Persad S; Troussard AA; McPhee TR; Mulholland DJ; Dedhar S
    J Cell Biol; 2001 Jun; 153(6):1161-74. PubMed ID: 11402061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
    Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
    Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
    Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
    Weng LP; Smith WM; Brown JL; Eng C
    Hum Mol Genet; 2001 Mar; 10(6):605-16. PubMed ID: 11230180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
    Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
    Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo.
    Ge NL; Rudikoff S
    Oncogene; 2000 Aug; 19(36):4091-5. PubMed ID: 10962569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.